|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
AU1537292A
(en)
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
|
AU661080B2
(en)
|
1991-11-22 |
1995-07-13 |
Warner Chilcott Company, Llc |
Risedronate delayed-release compositions
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
KR100291362B1
(ko)
|
1992-10-16 |
2001-09-17 |
니뽄 신야쿠 가부시키가이샤 |
왁스매트릭스의제법
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
EP0827402A2
(en)
|
1995-05-17 |
1998-03-11 |
Cedars-Sinai Medical Center |
Compositions containing fatty acids for improving digestion and absorption in the small intestine
|
|
DE19624292A1
(de)
|
1996-06-18 |
1998-01-02 |
Merckle Gmbh |
Verfahren und Zwischenprodukte zur Herstellung von 1'-Hydroxybenzbromaron
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
JP4814789B2
(ja)
|
2004-06-10 |
2011-11-16 |
鳥居薬品株式会社 |
６−ヒドロキシベンズブロマロン又はその塩からなる医薬組成物
|
|
US20080305169A1
(en)
|
2006-05-26 |
2008-12-11 |
Japan Tobacco Inc. |
Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
|
|
CN101765582A
(zh)
|
2007-04-26 |
2010-06-30 |
奥斯拜客斯制药有限公司 |
氘标记的氯胺酮
|
|
BRPI0913129A2
(pt)
*
|
2008-05-22 |
2016-01-05 |
Bristol Myers Squibb Co |
método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo
|
|
JP5325065B2
(ja)
|
2009-09-30 |
2013-10-23 |
株式会社富士薬品 |
新規フェノール誘導体
|
|
IT1400609B1
(it)
*
|
2010-05-10 |
2013-06-14 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e metformina e loro uso.
|
|
JP5844376B2
(ja)
|
2010-10-06 |
2016-01-13 |
ジェイファーマ株式会社 |
強力な尿酸トランスポーター阻害剤の開発：それらの尿酸排泄効果のために設計された化合物
|
|
US20150031768A1
(en)
|
2011-08-19 |
2015-01-29 |
The Trustees Of Princeton University |
C-halogen bond formation
|
|
US9060987B2
(en)
|
2011-11-04 |
2015-06-23 |
Cymabay Therapeutics, Inc. |
Methods for treating gout flares
|
|
US9962362B2
(en)
*
|
2012-03-29 |
2018-05-08 |
Children's Hospital Medical Center |
Use of small molecule inhibitors targeting EYA tyrosine phosphatase
|
|
WO2013152860A2
(en)
|
2012-04-11 |
2013-10-17 |
Dutalys Gmbh |
Improved antibody light chains
|
|
WO2013184572A1
(en)
|
2012-06-04 |
2013-12-12 |
Pharmacyclics, Inc. |
Crystalline forms of a bruton's tyrosine kinase inhibitor
|
|
JP6664219B2
(ja)
|
2012-08-14 |
2020-03-13 |
ミネルバ バイオテクノロジーズ コーポレーション |
幹細胞増強治療法
|
|
BR112015013020A2
(pt)
|
2012-12-05 |
2017-07-11 |
Dutalys Gmbh |
método de geração de anticorpos biespecíficos, coleção de anticorpos ou seus fragmentos funcionais, de sequências de ácidos nucleicos, de vetores e de células hospedeiras, método de produção da coleção de anticorpos e de identificação de um anticorpo, anticorpo ou fragmento funcional e anticorpo biespecífico
|
|
WO2014113407A2
(en)
*
|
2013-01-16 |
2014-07-24 |
Children's Hospital Medical Center |
Use of small molecule inhibitors targeting eya tyrosine phosphatase
|
|
EP2968235B1
(en)
*
|
2013-03-15 |
2017-09-13 |
Janssen Pharmaceutica NV |
Combination of canagliflozin and probenecid for the treatment of hyperuricemia
|
|
US20140357683A1
(en)
|
2013-05-31 |
2014-12-04 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods of treatment and compositions with xanthine oxidase inhibitors
|
|
WO2015134467A1
(en)
|
2014-03-05 |
2015-09-11 |
The Trustees Of Princeton University |
Methods and compositions for direct radioactive labeling of bio-active molecules and building blocks
|
|
JP6571756B2
(ja)
|
2014-07-31 |
2019-09-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
神経変性疾患に適応可能なインドリジン誘導体
|
|
CN104262305B
(zh)
|
2014-09-16 |
2016-06-08 |
东北制药集团股份有限公司 |
一种苯溴马隆晶型a及其制备方法
|
|
CN104311516B
(zh)
|
2014-09-16 |
2017-01-11 |
东北制药集团股份有限公司 |
一种苯溴马隆晶型b及其制备方法
|
|
SG11201900405XA
(en)
*
|
2016-07-18 |
2019-02-27 |
Arthrosi Therapeutics Inc |
Compounds, compositions and methods for treating or preventing a sympton associated with gout or hyperuricemia
|
|
WO2018090921A1
(zh)
|
2016-11-16 |
2018-05-24 |
江苏新元素医药科技有限公司 |
Urat1抑制剂及其应用
|
|
CN109415333B
(zh)
|
2016-12-14 |
2022-07-12 |
株式会社Lg化学 |
杂环化合物及包含其的有机发光元件
|
|
US20210130312A1
(en)
|
2018-04-03 |
2021-05-06 |
Children's Hospital Medical Center |
Inhibitors of eya3-protein tyrosine phosphatase in dna damage repair signaling of pulmonary arterial hypertension
|
|
BR112021006002A2
(pt)
|
2018-10-01 |
2021-06-29 |
Astrazeneca Ab |
composições para a redução de ácido úrico sérico
|
|
KR102946486B1
(ko)
|
2018-12-06 |
2026-03-31 |
아쓰로시 테라퓨틱스, 인크. |
통풍 또는 고뇨산혈증의 치료 또는 예방을 위한 화합물의 결정형
|
|
WO2020118114A1
(en)
|
2018-12-06 |
2020-06-11 |
Arthrosi Therapeutics, Inc. |
Methods for treating or preventing gout or hyperuricemia
|
|
SG11202112562XA
(en)
|
2019-05-14 |
2021-12-30 |
Arthrosi Therapeutics Inc |
Compound for treating gout or hyperuricemia
|
|
CN112952564B
(zh)
|
2019-12-25 |
2022-04-22 |
华为数字能源技术有限公司 |
配电模块及通信电源系统
|
|
AU2021288679A1
(en)
|
2020-06-10 |
2023-02-02 |
Arthrosi Therapeutics, Inc. |
Methods for treating or preventing chronic kidney disease
|
|
CN112729156A
(zh)
|
2020-12-24 |
2021-04-30 |
上海智能制造功能平台有限公司 |
一种人体数字化测量装置的数据拼接及系统标定方法
|
|
CN114697265A
(zh)
|
2020-12-29 |
2022-07-01 |
华为技术服务有限公司 |
一种报文处理方法及装置
|
|
TW202330485A
(zh)
|
2021-12-02 |
2023-08-01 |
美商安索治療公司 |
用於治療或預防痛風或高尿酸血症之化合物的結晶形式
|
|
US20250100988A1
(en)
|
2021-12-30 |
2025-03-27 |
Arthrosi Therapeutics, Inc. |
Preparation of a compound for the treatment of gout or hyperuricemia
|